Compounds > imatinib mesylate
Page last updated: 2024-09-03

imatinib mesylate and Anti-GBM Disease

imatinib mesylate has been researched along with Anti-GBM Disease in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Akizawa, T; Iyoda, M; Kuno, Y; Matsumoto, K; Shibata, T; Shindo-Hirai, Y; Wada, Y1
Moeller, MJ; Smeets, B1

Other Studies

2 other study(ies) available for imatinib mesylate and Anti-GBM Disease

ArticleYear
Long- and short-term treatment with imatinib attenuates the development of chronic kidney disease in experimental anti-glomerular basement membrane nephritis.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:3

    Topics: Animals; Anti-Glomerular Basement Membrane Disease; Benzamides; Collagen Type I; Creatinine; Disease Progression; Female; Fluorescent Antibody Technique; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Proteinuria; Pyrimidines; Rats; Rats, Inbred WKY; Real-Time Polymerase Chain Reaction; Renal Insufficiency, Chronic; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Time Factors; Transforming Growth Factor beta

2013
Novel target in the treatment of RPGN: the activated parietal cell.
    Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013, Volume: 28, Issue:3

    Topics: Animals; Anti-Glomerular Basement Membrane Disease; Benzamides; Female; Imatinib Mesylate; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Renal Insufficiency, Chronic

2013